Data for the PK parameter AUC3-t, mesalazine prolonged release granules were comparable to the PENTASA polonged release tablets, with the 90% CI for ratio of treatment geometric means contained within the limit 80%‑125% range (90% CI: 96.69% [84.20 to 111.03], p=0.6843). The AUC0‑3 ratio and lower bound 90% CI below 80% and 90% CI being within BE range for AUC3-t suggests lower systemic mesalazine exposure with the mesalazine prolonged release granules in early times up to 3 hours and similar mesalazine exposure after 3 hours, as compared to the PENTASA prolonged release tablets.